Here are four points:
1. In total, Amedica issued 3.6 million shares of common stock, 7,392 shares of preferred stock convertible into 7.4 million shares of common stock as well as warrants to purchase 11 million shares of common stock.
2. The underwriters have exercised their option to purchase 1.6 million additional shares of common stock and warrants to purchase up to an additional 1.6 million shares of common stock.
3. The company will use the gross proceeds of $12.7 million (before deducting underwriting discounts and commissions and Amedica’s estimated offering expenses) to support its growth.
4. Ladenburg Thalmann, a subsidiary of Ladenburg Thalmann Financial Services, and Maxim Group acted as joint book-running managers in connection with the offering.
More articles on devices:
Entellus Medical to exclusively distribute Fiagon’s navigation systems: 3 points
Zimmer Biomet celebrates 40 years of Oxford Partial Knee System use: 4 key takeaways
Asia Pacific spine surgery devices market to hit $2.22B by 2019 — 5 observations
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
